THE GLOBAL PLATFORM FOR THE
PREVENTION OF AUTOIMMUNE DIABETES (GPPAD)
RESEARCH FOR A WORLD
WITHOUT TYPE 1 DIABETES

Joint Effort across Europe.

Welcome to our Sites.

map of europe and detail of america with sites
Munich GERMANY

Lead investigator:
Prof. Anette-Gabriele Ziegler & Dr Christiane Winkler

Phone: 00800-33 15 33 15
Email: cc@gppad.org

Dresden GERMANY

Lead investigator:
Prof. Ezio Bonifacio & Prof. Dr Reinhard Berner

Phone: 0800-72 45 148
Email: diabetesstudie.crtd@tu-dresden.de

Hanover GERMANY

Lead investigator:
Prof. Dr Olga Kordonouri & Prof. Dr Thomas Danne

Phone: 0800-37 33 37 15
Email: freder1k@hka.de

Leuven BELGIUM

Lead investigator:
Prof. Kristina Casteels

Phone: +32-(0)-16-348554
Email: freder1kstudie@uzleuven.be

Newcastle UK

Lead investigator:
Prof. Steve Robson & Dr Catherine Owen

Phone: +44-(0)-191-2820553
Email: sharon.king10@nhs.net

Warsaw POLAND

Lead investigator:
Dr Agnieszka Szypowska & Dr Mariusz Ołtarzewski

Phone: +48-(0)-22 317 94 44
Email: kontakt@swiatbezjedynki.pl

Malmö SWEDEN

Lead investigator:
Prof. Helena Elding Larsson & Prof. Dr Markus Lundgren

Phone: +46-(0)-40-39 11 33
Email: gppad@med.lu.se

Oxford UK

Lead investigator:
Dr. Rachel Besser

Phone: +44-(0)-1865-572258
Email: INGR1D@wrh.ox.ac.uk

Cambridge UK

More info will follow!

Finland

Lead investigator:
Heikki Hyöty

Phone: +358-50-5168480
Email: heikki.hyoty@tuni.fi

France

Lead investigator:
Encarnita Mariotti-Ferrandiz

Email: encarnita.mariotti@sorbonne-universite.fr

London UK

Lead investigator:
Timothy Tree

Email: timothy.tree@kcl.ac.uk

London UK

Lead investigator:
Margarita Dominguez-Villar

Email: m.dominguez-villar@imperial.ac.uk

Bristol UK

Lead investigator:
Kathleen Gillespie

Email: K.M.Gillespie@bristol.ac.uk

USA

Lead investigator:
Tomi Pastinen

Email: tpastinen@cmh.edu

SHARING DATA TO DRIVE INNOVATIONS.

Repository for biospecimen and data.

Furthermore, GPPAD provides researchers worldwide with the opportunity to conduct innovative research on biospecimens from the GPPAD studies, aiming to make significant advances in the study of the etiology, pathogenesis, and prevention of type 1 diabetes and other immune-mediated diseases.